Valuation Alkermes plc

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-09 pm EDT			5-day change	1st Jan Change
28.45 ^USD	-0.63%		-5.95%	+1.68%

Mar. 02	Monopar Therapeutics Inc. Appoints Susan Rodriguez as Chief Commercial and Strategy Officer, Effective from March 2, 2026	CI
Feb. 26	RBC Lowers Price Target on Alkermes to $45 From $47, Keeps Outperform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	3,761	4,293	4,629	4,653	4,620	4,741	-	-
Change	-	14.15%	7.82%	0.52%	-0.72%	2.62%	-	-
Enterprise Value (EV) ¹	3,291	3,847	4,107	4,362	4,032	5,782	5,563	5,258
Change	-	16.87%	6.76%	6.23%	-7.58%	43.42%	-3.79%	-5.48%
P/E ratio	-77.5x	-26.9x	13.2x	13.3x	19.6x	-42.6x	38.9x	19.6x
PBR	3.36x	4.11x	3.85x	3.18x	2.55x	2.51x	2.26x	1.95x
PEG	-	-0x	-0x	3.99x	-0.6x	0x	-0x	0.2x
Capitalization / Revenue	3.2x	3.86x	2.78x	2.99x	3.13x	2.64x	2.53x	2.31x
EV / Revenue	2.8x	3.46x	2.47x	2.8x	2.73x	3.22x	2.96x	2.56x
EV / EBITDA	66.7x	-59.7x	8.44x	9.64x	14.1x	16.8x	14.6x	11.2x
EV / EBIT	-112x	-27x	9.92x	10.4x	15.9x	-108x	23.8x	14.4x
EV / FCF	44.7x	-224x	11.6x	10.8x	8.39x	8.92x	14x	10.8x
FCF Yield	2.24%	-0.45%	8.6%	9.3%	11.9%	11.2%	7.13%	9.25%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.3	-0.97	2.1	2.17	1.43	-0.6676	0.7311	1.454
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,174	1,112	1,663	1,558	1,476	1,795	1,876	2,050
EBITDA ¹	49.37	-64.4	486.7	452.4	285.6	343.6	382.2	469.4
EBIT ¹	-29.29	-142.3	414.1	420.6	254	-53.78	234.1	364.1
Net income ¹	-48.17	-158.3	355.8	367.1	241.7	-112.3	136	254.4
Net Debt ¹	-469.9	-446.8	-522.6	-291.1	-588.4	1,041	821.7	517
Reference price ²	23.26	26.13	27.74	28.76	27.98	28.45	28.45	28.45
Nbr of stocks (in thousands)	161,705	164,312	166,881	161,803	165,118	166,650	-	-
Announcement Date	2/16/22	2/16/23	2/15/24	2/12/25	2/25/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALKERMES PLC	-42.62x	3.22x	16.83x	-.--%	4.74B
LONZA GROUP AG	34.9x	5.09x	17.05x	0.98%	44.96B
BEONE MEDICINES AG	54.56x	4.74x	31.92x	-.--%	33.54B
CELLTRION, INC.	54.18x	11.1x	31.05x	0.35%	30.24B
IQVIA HOLDINGS INC.	21.65x	2.5x	10.76x	-.--%	29.97B
REVOLUTION MEDICINES, INC.	-13.03x	339.81x	-11.06x	-.--%	19.78B
ASCENDIS PHARMA A/S	45.18x	8.64x	27.12x	-.--%	14.73B
MEDPACE HOLDINGS, INC.	27.99x	4.48x	20.35x	-.--%	13.58B
EUROFINS SCIENTIFIC SE	20.77x	1.91x	8.36x	1.19%	12.97B
IONIS PHARMACEUTICALS, INC.	-18.64x	14.54x	-20.27x	-.--%	12.45B
Average	18.49x	39.60x	13.21x	0.25%	21.7B
Weighted average by Cap.	29.08x	36.54x	16.09x	0.32%